Corneal Transplant Market Outlook - 2027
Corneal transplant surgery is referred as the surgical procedure performed with the objective of replacing the part of patients’ cornea with corneal tissue from a donor. Actually, cornea is transparent, dome shaped surface of the eye. Its where the light enters the eye, and is a large part of the eye used to view clearly. This procedure has the ability to restore vision, reduce pain, and improve the appearance of the damaged or diseased cornea. Several incidences like bulging out of the cornea (keratoconus), Fuchs’ dystrophy (a hereditary condition), thinning and tearing of the cornea, cornea scarring, caused by infection or injury, swelling of the cornea, corneal ulcers not responding to medical treatment, and complications caused by previous eye surgery can be treated by the corneal transplant surgery. Although it has safety and accuracy features but it still poses some of the risks too. It can cause severe eye infection, ocular hypertension, and rise in problems associated with the stiches used to secure the donor cornea, bleeding and various retinal problems like retinal detachment or swelling. This process includes the following methods like penetrating keratoplasty, endothelial keratoplasty, anterior lamellar keratoplasty, and artificial cornea transplant (keratoprosthesis). These methods may result in the blurry vision for a period of time after surgery. It may depend on the patient to patient condition like it may take 6 weeks to 12 weeks to get the full benefits of the surgery.
COVID-19 Scenario Analysis:
At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global corneal transplant market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.
Top impacting factors: market scenario analysis, trends, drivers, impact analysis
Some of the major factors responsible for driving the growth of the market are increase in the prevalence of the corneal eye disease, rise in the number of the patients, surge in the number of the corneal transplants in the world, and increase in the demand for minimally invasive surgical procedures among the consumers. Furthermore, rise in the awareness regarding corneal transplants that provide aesthetic benefits also help increase the growth of the corneal transplant market. Growth in geriatric population is expected to fuel the growth of the market. Additionally, increase in the advantage associated with the minimally invasive treatment and rise in the investments can lead to enhancements in the growth of the market. Moreover, rise in various technological advancements in the treatment facilities extend the growth of the corneal transplant market.
However, high cost of the treatment and shortage of the donor material are the factors posing the key restraints in the growth of the corneal transplant market.
New product launches to flourish the market:
In October 2018, Medical Technology Group of Zeiss received the U.S. FDA premarket approval for its ReLex Smile PMA, it helped in expanding myopia treatment to patients with astigmatism.
In June 2018, the first eye bank in the government sector in the entire southern region was inaugurated at Sarojini Devi Eye Hospital. It was launched for health and family welfare. It was launch to provide corneal transplant facility at free of cost to the poor patients.
Surge in the cases of corneal transplant:
Increase in the prevalence of the corneal eye diseases and awareness about the corneal transplant drive the demand of corneal transplant technology. Moreover, increase in the advancements in the procedure and the instruments fuels the usage of the corneal transplant.
Key benefits of the report:
- This study presents the analytical depiction of the global corneal transplant industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global corneal transplant market share.
- The current market is quantitatively analyzed to highlight the global corneal transplant market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global corneal transplant market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the corneal transplant market research report:
- Which are the leading market players active in the corneal transplant market?
- What are the current trends that will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Corneal Transplant Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By Indication |
|
 By End user |
|
 By Region |
|
 Key Market Players | Organogenesis Inc., Lifeline Scientific, CryoLife Inc., Kohler GmbH, Presbia plc., Corneat Vision, Medtronic plc., Exactech, Inc., Lifecell Corporation, Ajl Ophthalmic SA, Keramed Inc. |
Loading Table Of Content...
